why choose us

First received: April 14, 2023

Clinical Trial: A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Solid Tumors

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Brief Summary: To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors.

Read more